Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Real Heart: Realheart establishes new partnerships

HEARTRegulatory press release05.05.2020, 14.13
Read the release

Realheart has reached a high level with respect to technical concept development of its artificial heart. In parallel with continued development work, the company is now looking for suitable partners to support Realheart in the continued development work of the version that will eventually be implanted in man.

After this winter's successful animal testing, Realheart's focus has been on reviewing the manufacturing strategy for the upcoming clinical trials. The company has identified two alternative routes. Either to build your own organization with the necessary resources, or to find certified suppliers and partners with expertise in the development of medical technology products.

Realheart estimates that large investments would be required over a couple of years to build up our own plant and organization. Therefore, in order to save time and money, the company has chosen to seek partners who have the necessary expertise in materials, development and manufacture of implantable medical products. Recently, Realheart has therefore worked actively to identify possible partners both in Sweden and internationally.